The Brotman Baty Institute for Precision Medicine, or BBI, was founded in November 2017 by UW Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s.
UW Medicine is comprised of five medical centers, a medical school, thirty academic departments at the University of Washington, a physicians’ practice group, neighborhood clinics, and a constellation of relationships with complementary organizations. It is ranked among the world’s very best medical schools and biomedical research institutions. It is a leading innovator in translating research into improved patient care, and has sits within the University of Washington, one of the world’s most highly-regarded research universities.
The Fred Hutchinson Cancer Research Center was founded to research, diagnose, treat, and eventually cure cancer. Today, “Fred Hutch” practices in a vertically-integrated way that includes fundamental scientific research, prevention, early detection, treatments and cures, and survivorship, and its research focus has expanded to include certain other especially challenging diseases including as HIV/AIDS, malaria, and influenza. It is a highly regarded and highly collaborative institution, working closely with Seattle’s other leading research entities to improve the rate at which breakthroughs in research create better outcomes for patients.
Seattle Children’s brings together one of the nation’s leading children’s hospitals and one of the nation’s leading pediatric research institutions, supported by a remarkable program of community engagement. The hospital addresses children’s physiological, emotional, behavioral and familial needs together to achieve the best outcomes. The research institute collaborates closely with the hospital, as well as with Seattle’s other research entities and hospitals. In 2019, Seattle Children’s will open the Cure Factory, a facility to manufacture cell therapies for children, a major advance in the practice of precision medicine.